These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5463297)

  • 21. Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.
    Broekman MJ; Handin RI; Cohen P
    Br J Haematol; 1975 Sep; 31(1):51-5. PubMed ID: 1212435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma transglutaminase activity in congenital total and partial factor XIII deficiency (a contribution to the problem of factor XIII determination)].
    Egbring R; Andrassy K; Egli H
    Thromb Diath Haemorrh; 1971; 25(1):166-77. PubMed ID: 5577969
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the relationship between factor XIII activity and fibrin clot solubility test by urea and monochloroacetic acid (author's transl)].
    Ukita M; Mikami K; Kitahara T; Kato M; Kani T; Yano Y
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):963-8. PubMed ID: 610332
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 27. [Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].
    Egbring R; Schmidt W; Havemann K
    Blut; 1973 Jul; 27(1):6-19. PubMed ID: 4718816
    [No Abstract]   [Full Text] [Related]  

  • 28. High-performance liquid chromatographic assay of transglutaminase and its application to the purification of human erythrocyte transglutaminase and platelet factor XIII.
    Ando Y; Imamura S; Yamagata Y; Kikuchi T; Murachi T; Kannagi R
    J Biochem; 1987 Jun; 101(6):1331-7. PubMed ID: 2889725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [2 patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination].
    Egbring R; Andrassy K; Egli H; Meyer-Lindenberg J
    Thromb Diath Haemorrh; 1970 May; 23(2):313-39. PubMed ID: 5426213
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation of a link between raised levels of pepsinogen in blood as a mediator of in-vitro clot lysis in acid and a cause of abnormal factor XIII screening tests.
    Duncan EM; Dale BJ; Lloyd JV
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):340-8. PubMed ID: 24440916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood platelets and fibrin stabilizing factor activity].
    Isobe J; Kawano K; Yamanaka M
    Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):696-7. PubMed ID: 5535827
    [No Abstract]   [Full Text] [Related]  

  • 34. The comparative studies on factor XIII of newborn infants obtained by three methods; clot solubility, immunological and fluorescent assays.
    Yamada K; Shirahata A; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):79-84. PubMed ID: 989234
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of Echis carinata venom on hemostasis].
    Zimmermann H; Habermann E; Lasch HG
    Thromb Diath Haemorrh; 1971 Jun; 25(3):425-37. PubMed ID: 5561955
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of coagulation factors on the surface of platelets.
    Walsh PN
    Haematologia (Budap); 1984; 17(1):57-66. PubMed ID: 6427070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The determination of coagulation factor XIII by the Bohn and Haupt method].
    Trobisch H
    Thromb Diath Haemorrh Suppl; 1973; 55():341-4. PubMed ID: 4807851
    [No Abstract]   [Full Text] [Related]  

  • 38. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular subunits and transamidase activity of factor XIII in patients with deep vein thrombosis.
    Kłoczko J; Wojtukiewicz M; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):810-4. PubMed ID: 2436995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets.
    Sixma JJ; van den Berg A; Schiphorst M; Geuze HJ; McDonagh J
    Thromb Haemost; 1984 Jul; 51(3):388-91. PubMed ID: 6388014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.